Literature DB >> 11286379

Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone.

T Lerman-Sagie1, P Rustin, D Lev, M Yanoov, E Leshinsky-Silver, A Sagie, T Ben-Gal, A Munnich.   

Abstract

Idebenone, a synthetic analogue of coenzyme Q10, has been shown to improve cardiac function in patients with Friedreich ataxia and a deficiency of respiratory chain complexes I-III. We describe a woman with severe combined right and left heart failure due to a mitochondrial cardiomyopathy. The patient underwent an endomyocardial biopsy as part of an evaluation for cardiac transplantation. It showed severely decreased respiratory complex activities dependent on CoQ, pointing to CoQ depletion. Following idebenone treatment there was a dramatic improvement in her clinical status with resolution of the heart failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286379     DOI: 10.1023/a:1005642302316

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant.

Authors:  K Folkers; P Langsjoen; P H Langsjoen
Journal:  Biochem Biophys Res Commun       Date:  1992-01-15       Impact factor: 3.575

2.  A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency.

Authors:  E Boitier; F Degoul; I Desguerre; C Charpentier; D François; G Ponsot; M Diry; P Rustin; C Marsac
Journal:  J Neurol Sci       Date:  1998       Impact factor: 3.181

3.  Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators.

Authors:  F Vaillant; J A Larm; G L McMullen; E J Wolvetang; A Lawen
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

Review 4.  Mitochondrial cardiomyopathy: molecular and biochemical analysis.

Authors:  J Marin-Garcia; M J Goldenthal
Journal:  Pediatr Cardiol       Date:  1997 Jul-Aug       Impact factor: 1.655

5.  Mitochondrial encephalomyopathy with coenzyme Q10 deficiency.

Authors:  C Sobreira; M Hirano; S Shanske; R K Keller; R G Haller; E Davidson; F M Santorelli; A F Miranda; E Bonilla; D S Mojon; A A Barreira; M P King; S DiMauro
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

6.  Endomyocardial biopsies for early detection of mitochondrial disorders in hypertrophic cardiomyopathies.

Authors:  P Rustin; J Lebidois; D Chretien; T Bourgeron; J F Piechaud; A Rötig; A Munnich; D Sidi
Journal:  J Pediatr       Date:  1994-02       Impact factor: 4.406

7.  Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.

Authors:  S Ogasahara; A G Engel; D Frens; D Mack
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Mitochondrial dysfunction in skeletal muscle of children with cardiomyopathy.

Authors:  J Marin-Garcia; R Ananthakrishnan; M J Goldenthal; J J Filiano; A Perez-Atayde
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

9.  Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.

Authors:  E Arbustini; M Diegoli; R Fasani; M Grasso; P Morbini; N Banchieri; O Bellini; B Dal Bello; A Pilotto; G Magrini; C Campana; P Fortina; A Gavazzi; J Narula; M Viganò
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 10.  Biochemical and molecular investigations in respiratory chain deficiencies.

Authors:  P Rustin; D Chretien; T Bourgeron; B Gérard; A Rötig; J M Saudubray; A Munnich
Journal:  Clin Chim Acta       Date:  1994-07       Impact factor: 3.786

View more
  8 in total

Review 1.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

2.  Refractory epilepsy and mitochondrial dysfunction due to GM3 synthase deficiency.

Authors:  Konstantina Fragaki; Samira Ait-El-Mkadem; Annabelle Chaussenot; Catherine Gire; Raymond Mengual; Laurent Bonesso; Marie Bénéteau; Jean-Ehrland Ricci; Valérie Desquiret-Dumas; Vincent Procaccio; Agnès Rötig; Véronique Paquis-Flucklinger
Journal:  Eur J Hum Genet       Date:  2012-09-19       Impact factor: 4.246

3.  Protective effects of Fe-Aox29, a novel antioxidant derived from a molecular combination of Idebenone and vitamin E, in immortalized fibroblasts and fibroblasts from patients with Friedreich Ataxia.

Authors:  Matthias L Jauslin; Silvia Vertuani; Elisa Durini; Lisa Buzzoni; Nunzia Ciliberti; Sara Verdecchia; Paola Palozza; Thomas Meier; Stefano Manfredini
Journal:  Mol Cell Biochem       Date:  2007-05-03       Impact factor: 3.396

4.  Clinical presentations of mitochondrial cardiomyopathies.

Authors:  D Lev; A Nissenkorn; E Leshinsky-Silver; M Sadeh; A Zeharia; B-Z Garty; L Blieden; V Barash; T Lerman-Sagie
Journal:  Pediatr Cardiol       Date:  2004-06-08       Impact factor: 1.655

Review 5.  Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities.

Authors:  Ligia Akemi Kiyuna; Rudá Prestes E Albuquerque; Che-Hong Chen; Daria Mochly-Rosen; Julio Cesar Batista Ferreira
Journal:  Free Radic Biol Med       Date:  2018-09-15       Impact factor: 7.376

Review 6.  The Value of Coenzyme Q10 Determination in Mitochondrial Patients.

Authors:  Delia Yubero; George Allen; Rafael Artuch; Raquel Montero
Journal:  J Clin Med       Date:  2017-03-24       Impact factor: 4.241

Review 7.  Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.

Authors:  David A Brown; Justin B Perry; Mitchell E Allen; Hani N Sabbah; Brian L Stauffer; Saame Raza Shaikh; John G F Cleland; Wilson S Colucci; Javed Butler; Adriaan A Voors; Stefan D Anker; Bertram Pitt; Burkert Pieske; Gerasimos Filippatos; Stephen J Greene; Mihai Gheorghiade
Journal:  Nat Rev Cardiol       Date:  2016-12-22       Impact factor: 32.419

Review 8.  Skeletal Muscle Mitochondrial Dysfunction and Oxidative Stress in Peripheral Arterial Disease: A Unifying Mechanism and Therapeutic Target.

Authors:  Kyoungrae Kim; Erik M Anderson; Salvatore T Scali; Terence E Ryan
Journal:  Antioxidants (Basel)       Date:  2020-12-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.